BioCentury
ARTICLE | Clinical News

Alphanate regulatory update

February 5, 2007 8:00 AM UTC

FDA approved Alphanate, an antihemophilic factor/ von Willebrand factor complex, to treat congenital von Willebrand disease (VWD). ...